Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Surg Oncol ; 28(2): 108-12, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11884044

RESUMEN

AIM: The aim of this study was to evaluate if Tc99m-sestamibi scintimammography in addition to the triple assessment consisting of clinical examination, mammography, breast ultrasonography and fine needle aspiration cytology (FNA) enhances the diagnosis of breast cancer and helps in avoiding unnecessary operative biopsies. METHODS: Pre-operational scintimammography was performed within 2 weeks of operation to 46 consecutive patients with abnormal findings in clinical breast examination, mammography or ultrasonography. Three patients had abnormalities in both breasts. Histological diagnosis was obtained in all 49 cases. RESULTS: The histological diagnosis was benign in 18 (37%) cases and malignant in 31 (63%) cases. The overall sensitivity of scintimammography was 77% and the specificity was 61%. The sensitivity of scintimammography was 95% in invasive ductal carcinoma, 50% in invasive lobular carcinoma and 25% in ductal carcinoma in situ. Scintimammography showed 100% sensitivity in cases with invasive carcinoma, with highly suspicious findings for malignancy in the other examinations. The sensitivity was 63% in cases with indeterminate or contradictory findings in mammography, ultrasonography and FNA. CONCLUSIONS: Adding scintimammography to the triple assessment does not seem to be helpful in the diagnosis of breast abnormalities because of low sensitivity in malignant cases with a challenging diagnosis by mammography, ultrasonography and FNA, and because of low overall specificity.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/patología , Mamografía/métodos , Intensificación de Imagen Radiográfica , Tecnecio Tc 99m Sestamibi , Anciano , Biopsia con Aguja , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/cirugía , Femenino , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Cintigrafía , Sensibilidad y Especificidad , Estadísticas no Paramétricas , Ultrasonografía/métodos
2.
Breast Cancer Res Treat ; 53(2): 161-6, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10326793

RESUMEN

Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and vascular permeability. Many types of malignant human tumors have been shown to produce VEGF. Recently, increased serum concentrations of VEGF (S-VEGF) have been reported in patients with various types of cancer, and high S-VEGF levels have also been associated with unfavorable prognosis. We have now measured S-VEGF in sera taken from 105 patients with a benign breast tumor or breast cancer. None of the women with a benign breast tumor had S-VEGF higher than 328 pg/ml (median, 57 pg/ml) whereas S-VEGF levels in metastatic breast cancer ranged from 7 to 1347 pg/ml (median, 186 pg/ml; P = 0.0018), and in locoregional breast cancer from 11 to 539 pg/ml (median, 104 pg/ml; P = 0.13). S-VEGF was higher in patients with locoregional ductal cancer (median, 107 pg/ml) than in those with locoregional lobular cancer (median, 44 pg/ml; P = 0.029) or in patients with benign breast tumor (median, 57 pg/ml; P = 0.033). Patients with metastatic cancer undergoing therapy had lower S-VEGF than those who had symptomatic treatment only (P = 0.021). The results indicate that dissemination of breast cancer may be accompanied by an elevation of circulating VEGF and that primary ductal cancers are associated with higher S-VEGF levels than lobular cancers or benign breast lesions.


Asunto(s)
Neoplasias de la Mama/sangre , Factores de Crecimiento Endotelial/sangre , Linfocinas/sangre , Neoplasias de la Mama/patología , Factores de Crecimiento Endotelial/fisiología , Femenino , Humanos , Linfocinas/fisiología , Metástasis de la Neoplasia , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular
5.
Anticancer Res ; 12(3): 599-606, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1320355

RESUMEN

Eighteen non-randomized patients with small cell lung cancer (4 women and 14 men, mean age 60.4, SD 7.8 years) received in addition to conservation small cell lung cancer treatment antioxidant treatment with vitamins, trace elements and fatty acids. All patients were out-patients who, except for one were also treated with chemotherapy and/or irradiation at regular intervals at a university of central hospital. Five patients (28%) were in an advanced stage of the disease. At the end of the follow-up period (31.7.90) the median survival time for the whole group was 505 days. Fourteen (77%) of the patients survived for more than 12 months and six patients (33%) for more than two years. One patient (5%) survived more than five years. Eight patients (44%) were still alive with a mean survival time of 32 months at the end of the study. Ten patients succumbed earlier from progression of the disease. Antioxidant treatment, in combination with chemotherapy and irradiation, prolonged the survival time of patients with small cell lung cancer compared to most published combination treatment regimens alone. We also noticed that the patients receiving antioxidants were able to tolerate chemotherapy and radiation treatment well. Surviving patients started antioxidant treatment in general earlier than those who succumbed.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Antioxidantes/uso terapéutico , Carcinoma de Células Pequeñas/terapia , Ácidos Grasos Esenciales/uso terapéutico , Neoplasias Pulmonares/terapia , Oligoelementos/uso terapéutico , Vitaminas/uso terapéutico , Carcinoma de Células Pequeñas/tratamiento farmacológico , Carcinoma de Células Pequeñas/radioterapia , Terapia Combinada , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/radioterapia , Masculino , Persona de Mediana Edad , Oligoelementos/sangre , Vincristina/administración & dosificación
7.
Ann Chir Gynaecol ; 80(3): 311-2, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1759803

RESUMEN

Primary iliac artery aneurysms are rare, and a fistula to the terminal ileum with bleeding is very uncommon. A case with a primary massively bleeding iliaco-ileal fistula is described. In an emergency operation the common iliac artery was ligated and the fistula to the small bowel was resected. Arterial reconstruction was done by extra-anatomical femoro-femoral suprapubic prosthesis. The immediate outcome of the operation was excellent, but the patient died four days later because of acute myocardial infarction.


Asunto(s)
Fístula , Hemorragia Gastrointestinal/etiología , Enfermedades del Íleon , Arteria Ilíaca , Fístula Intestinal , Anciano , Fístula/complicaciones , Fístula/diagnóstico , Fístula/cirugía , Humanos , Enfermedades del Íleon/complicaciones , Enfermedades del Íleon/diagnóstico , Enfermedades del Íleon/cirugía , Fístula Intestinal/complicaciones , Fístula Intestinal/diagnóstico , Fístula Intestinal/cirugía , Masculino
8.
J Surg Oncol ; 33(2): 115-9, 1986 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3762183

RESUMEN

The clinical results from postoperative active specific immunotherapy using autologous polymerized tumor material in six patients suffering from metastasized melanoma is reported. Correction of an alleged systemic deficiency leading to malignant cell transformation was attempted by administering certain essential trace elements, amino acids, vitamins, and a diet containing lipids, extracted from the mammalian central nervous system, after heating. Vaccinations against influenza were also given as a precaution against certain viral infections sometimes seen to precede melanoma recurrence. The clinical results with this postoperative adjuvant therapy are so encouraging that we suggest that sterile tumor tissue should be saved at operation and treated to produce insoluble particles as an option for postoperative treatment of patients suffering from metastasized melanoma. Prospective randomized studies are indicated.


Asunto(s)
Inmunoterapia , Melanoma/terapia , Neoplasias Cutáneas/terapia , Adulto , Anciano , Antígenos de Neoplasias/administración & dosificación , Antígenos de Neoplasias/inmunología , Terapia Combinada , Femenino , Humanos , Gripe Humana/prevención & control , Masculino , Melanoma/dietoterapia , Melanoma/cirugía , Persona de Mediana Edad , Metástasis de la Neoplasia , Recurrencia Local de Neoplasia , Neoplasias Cutáneas/dietoterapia , Neoplasias Cutáneas/cirugía , Vacunación
9.
Scand J Gastroenterol ; 20(1): 5-12, 1985 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3922048

RESUMEN

In a randomized double-blind study the effect of CaNa2EDTA, a phospholipase A2 inhibitor, was tested as a treatment for acute pancreatitis. CaNa2EDTA was infused intravenously during the first 2 days after admission to hospital, in addition to normal conservative treatment. CaNa2EDTA decreased the serum phospholipase A2 activity and appeared to promote recovery from the illness. To what extent the inhibition of serum phospholipase activity may prevent the progress of severe haemorrhagic pancreatitis or diminish mortality and morbidity in acute pancreatitis should be investigated in further studies.


Asunto(s)
Proteínas de Unión al Calcio , Ácido Edético/uso terapéutico , Glicoproteínas/uso terapéutico , Pancreatitis/tratamiento farmacológico , Fosfolipasas A/antagonistas & inhibidores , Fosfolipasas/antagonistas & inhibidores , Enfermedad Aguda , Anexinas , Ensayos Clínicos como Asunto , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pancreatitis/metabolismo , Fosfolipasas A2 , Distribución Aleatoria
10.
Eur Urol ; 11(4): 233-43, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-2412827

RESUMEN

The results of a 13-year (1971-1984) follow-up of specific active immunotherapy using polymerized autologous tumor tissue with adjuvants and supportive measures, following palliative nephrectomy in 71 patients suffering from advanced renal adenocarcinoma, are presented. The control patient group comprised 56 patients who received the best possible conservative treatment available. The statistically calculated life expectancy in the immunotherapy group is 44.5 months (SE 5.7) and in the control group 19.0 months (SE 3.3). The difference is statistically highly significant (generalized Wilcoxon [Breslow], t = 14.9, p less than 0.0001). There were no serious side effects from the immunization. The supportive measures entailing the administration of factors involved in cell regulatory functions mediated by the central nervous system, amino acids, trace elements, hormones and vitamins has still to be optimized.


Asunto(s)
Carcinoma de Células Renales/terapia , Inmunoterapia , Neoplasias Renales/terapia , Cuidados Paliativos , Vacunación , Adyuvantes Inmunológicos/uso terapéutico , Adulto , Anciano , Carcinoma de Células Renales/mortalidad , Carcinoma de Células Renales/cirugía , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Renales/mortalidad , Neoplasias Renales/cirugía , Esperanza de Vida , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Nefrectomía , Factores de Tiempo
11.
Arch Surg ; 116(2): 153-6, 1981 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7469742

RESUMEN

Death due to appendicitis is still a significant occurrence. The stage when the disease is diagnosed and operation occurs has a decisive influence on the mortality. In our series of 9,652 cases of appendicitis, 26 patients died (0.27%)-ten (0.12%) of nonperforative appendicitis, and 16 (1.18%) of perforative appendicitis. Both the patients and the physician can delay treatment. The proportion of fatal cases is six times as great in perforative appendicitis is in those operated on in time. The deaths in those with a perforated appendix were usually caused by the basic disease or the surgical procedure, while in patients with unperforated appendixes, death was most commonly caused by other concomitant diseases. The proportion of the elderly in our series increased along with the rise in the average age of the population. The symptoms of acute appendicitis and the clinical findings are identical in the elderly and in the younger patients, but the disease in the aged advanced more rapidly to perforation and the mortality among them was higher. Active and careful attention to patients with possible diagnosis of appendicitis, especially in the elderly, is important.


Asunto(s)
Apendicitis/mortalidad , Enfermedad Aguda , Adolescente , Adulto , Factores de Edad , Anciano , Apendicitis/complicaciones , Apendicitis/cirugía , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Rotura Espontánea
13.
Scand J Gastroenterol ; 15(5): 519-28, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-6777862

RESUMEN

A laboratory method was established for measurement of phospholipase A2 activity in buffer and serum. A series of different phospholipase A2 inhibitors was tested. The most effective inhibitors were Ca2+ chelating compounds like EDTA, DTPA, EGTA, and phytic acid. The calcium salt of EDTA also has some inhibitory effect. Serum phospholipase A2 activity in normal healthy control patients was measured. The activity in 27 patients with acute pancreatitis was tested. The activity was abnormally high in five patients. This activity was in vitro inhibited by EDTA and partly by CaNa2EDTA. The clinical picture of these patients did not differ from that of phospholipase-A2-negative patients. Six patients with acute pancreatitis were treated by intravenous infusion of CaNA2EDTA. Two of them had haemorrhagic pancreatitis and two were suspected of having early haemorrhagic pancreatitis. During the CaNa2EDTA infusion serum amylase and phospholipase A2 activities decreased. All patients recovered. No harmful side effects were noticed.


Asunto(s)
Quelantes/uso terapéutico , Pancreatitis/tratamiento farmacológico , Fosfolipasas A/antagonistas & inhibidores , Fosfolipasas/antagonistas & inhibidores , Enfermedad Aguda , Adulto , Anciano , Ácido Edético/uso terapéutico , Ácido Egtácico/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pancreatitis/sangre , Ácido Pentético/uso terapéutico , Fosfolipasas A/sangre , Fosfolipasas A2 , Ácido Fítico/uso terapéutico
17.
Med Biol ; 56(4): 194-200, 1978 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-212651

RESUMEN

Serum antibodies against BK virus (BKV) and seven other viruses were studied in 76 patients with renal cell carcinoma using either the haemagglutination inhibition or the complement fixation techneque. BKV and herpes simplex virus (HSV), but no other virus antibodies, showed a clear correlation with the clinical course of renal carcinomas. The patients without BKV antibodies or with marginal antibody titres (titre less than or equal to 10), had a significantly longer observed expectation of life (O.E. life, 44.1 months) than the O.E. life (26.7 months) of the patients with BKV antibodies of titre less than or equal to 20. Similarly, patients with low or undetectable HSV antibodies (titre less than or equal to 8) also had significantly longer O.E. life (54.0 months) than the rest of the patients (32.7 months). The results suggest that BKV and HSV have an as yet underfined relationship to renal cell carcinomas.


Asunto(s)
Adenocarcinoma/inmunología , Anticuerpos Antivirales , Virus BK/inmunología , Neoplasias Renales/inmunología , Poliomavirus/inmunología , Simplexvirus/inmunología , Adenocarcinoma/mortalidad , Adulto , Anciano , Anticuerpos Antivirales/análisis , Pruebas de Fijación del Complemento , Femenino , Pruebas de Inhibición de Hemaglutinación , Humanos , Neoplasias Renales/mortalidad , Masculino , Persona de Mediana Edad , Pronóstico
18.
J Clin Microbiol ; 8(2): 113-8, 1978 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-701458

RESUMEN

Serial serum samples from patients with acute pancreatitis showed a significant increase in antibodies against methanol-chloroform-extracted lipid antigen from Mycoplasma pneumoniae when tested by complement fixation. The antibodies did not react with antigens prepared from other human mycoplasmas or from pancreatic tissue by lipid extraction. The antibodies were predominantly immunoglobulin M (IgM). No correlation with cold agglutinins or cardiolipid complement-fixing antibodies was found. The IgM antibody response seemed to be prolonged: after 3 to 4 weeks the antibodies were still in many cases exclusively IgM. Similar IgM responses were also found in certain cases of acute meningoencephalitis. We postulate that during the disease antigenic components identical or very similar to major determinants in the M. pneumoniae lipid antigen are revealed and elicit the IgM antibody response. Their resemblance to natural antibodies and their possible biological role is discussed.


Asunto(s)
Anticuerpos Antibacterianos/biosíntesis , Antígenos , Inmunoglobulina M/biosíntesis , Lípidos/inmunología , Mycoplasma/inmunología , Pancreatitis/inmunología , Enfermedad Aguda , Especificidad de Anticuerpos , Pruebas de Fijación del Complemento , Humanos
19.
Eur Urol ; 4(4): 250-8, 1978.
Artículo en Inglés | MEDLINE | ID: mdl-668735

RESUMEN

The results of a specific active immunotherapy method following palliative nephrectomy in 31 patients suffering from advanced renal-cell carcinoma are presented. The control patient group comprised of 23 comparable cases, who did not receive immunotherapy. The minimum follow-up time for any patient is 4 years. The statistical 5-year survival rate of the immunotherapy group is 23.6% (SE = 7.8). 7 patients are still alive. The 5-year survival rate of the control group is 4.3% (SE = 4.3), without a single survival. The difference is statistically highly significant (p less than 0.001). No side effects were noted from this form of immunotherapy.


Asunto(s)
Adenocarcinoma/terapia , Inmunoterapia , Neoplasias Renales/terapia , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Pulmonares , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia
20.
Ann Chir Gynaecol Suppl ; 66(5): 230-3, 1977.
Artículo en Inglés | MEDLINE | ID: mdl-413467

RESUMEN

Solitary diverticulum of the caecum is very rare and assumes clinical interest only when inflamed. Preoperatively the condition is virtually impossible to distinguish from acute appendicitis, and even during operation its differentiation from carcinoma is difficult. It is also important to determine whether or not an underlying solitary diverticulum of the caecum is present. In the present series the symptoms and clinical examination as well as laboratory findings pointed to acute appendicitis, which was in fact the preoperative diagnosis in all our patients. In one case the operative findings were strongly suggestive of carcinoma, which was only excluded by inspection and histological examination of the specimen. The wall of the diverticulum was necrotic in all cases. It had already perforated in the previously mentioned case, and right hemicolectomy was performed. An inflamed, but recognizable, solitary diverticulum of the caecum was treated by excision, but the tumour-like mass produced by the diverticulum was removed by resection. In view of the considerable possibility of underlying carcinoma, the authors support an aggressive trend in the treatment of "inflammatory tumours" of the caecal wall.


Asunto(s)
Enfermedades del Ciego/complicaciones , Diverticulitis/diagnóstico , Divertículo/complicaciones , Adulto , Apendicitis/diagnóstico , Neoplasias del Ciego/diagnóstico , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Necrosis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA